Menu
Estimation of benefits, harms, and resource requirements of current screening programs and the impact of addressing barriers and facilitators or enablers
Summary
The EU-TOPIA web tool will be extended with data collected for the exemplary countries in WP4: Slovakia, Romania, Hungary, Estonia, Ukraine and Slovenia. Parts of the tool will be cross-validated against UMIT TIROL models focusing on CRC. Finally, the tool will be applied for simulation of current situations and barriers and facilitators for all participating countries identified in WP6. Non-exemplary countries will be supported in collecting data for use in the model, application of the web tool and interpretation of model results.
This task will be led by EMC, Netherlands.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
